Evidence map›Paper›PMID 35213685›Full record

ReviewBlood2022

Neutrophil dysfunction in the pathogenesis of cystic fibrosis.

Guoshun Wang, William M Nauseef

Open access · bronzeAbstract readReview
In one paragraph

Review in Blood, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Functional CFTR may be required for Prevotella melaninogenica regulation of epithelial cell defense against Staphylococcus aureus.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2026
    Article
  5. Phage-Based Approaches to ChronicAntibiotics (Basel, Switzerland) · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. The Challenges of Detecting Neutrophil CFTR.Journal of innate immunity · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. Neutrophil store-operated CaJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Insights on the Pathogenesis ofJournal of clinical medicine · 2025
    Review
  18. Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Guoshun WangDepartment of Microbiology, Immunology, and Parasitology, and.ORCID 0000-0002-4057-1399
William M NauseefInflammation Program, Department of Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA; and.ORCID 0000-0003-4032-757X
Louisiana State University Health Sciences Center New Orleans · USUniversity of Iowa · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Determinants of human neutrophil fate after phagocytosisR01AI132335 · NIAID · UNIVERSITY OF IOWA · PI NAUSEEF, WILLIAM M. · 2018 to 2022
$2.4M
Consequences of interactions between human neutrophils and Staphylococcus aureusR01AI116546 · NIAID · UNIVERSITY OF IOWA · PI NAUSEEF, WILLIAM M. · 2015 to 2019
$1.8M
Innate Immune Defect and Neutrophilic Inflammation in Cystic FibrosisR01HL150370 · NHLBI · LSU HEALTH SCIENCES CENTER · PI WANG, GUOSHUN · 2020 to 2023
$1.5M
Myeloid CFTR Defect and CF Pathogen SelectionR21AI140088 · NIAID · LSU HEALTH SCIENCES CENTER · PI WANG, GUOSHUN · 2019 to 2020
$404k
NHLBI NIH HHS R01 HL150370NIAID NIH HHS R01 AI116546NIAID NIH HHS R01 AI132335NIAID NIH HHS R21 AI140088NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Polymorphonuclear neutrophils (PMNs) figure prominently in host defense against infection and in noninfectious inflammation. Mobilized early in an inflammatory response, PMNs mediate immediate cellular defense against microbes and orchestrate events that culminate in cessation of inflammation and restoration of homeostasis. Failure to terminate the inflammatory response and its causes can fuel exuberant inflammation characteristic of many human diseases, including cystic fibrosis (CF), an autosomal recessive genetic disease caused by mutations in the CF transmembrane conductance regulator. CF affects multiple end organs, with persistent bacterial infection and chronic neutrophilic inflammation in airways predominating the clinical picture. To match the diverse microbial challenges that they may encounter, PMNs possess a variety of antimicrobial systems to slow or kill invading microorganisms confined in their phagosomes. Prominent among PMN defense systems is their ability to generate hypochlorous acid, a potent microbicide, by reacting oxidants generated by the NADPH oxidase with myeloperoxidase (MPO) released from azurophilic granules in the presence of chloride (Cl-). Products of the MPO-H2O2-Cl system oxidize susceptible biomolecules and support robust antimicrobial action against many, but not all, potential human pathogens. Underscoring that the MPO-H2O2-Cl system is integral to optimal host defense and proper regulation of inflammation, individuals with defects in any component of this system, as seen in chronic granulomatous disease or MPO deficiency, incur increased rates or severity of infection and signs of dysregulated inflammatory responses. We focus attention in this review on the molecular basis for and the clinical consequences of defects in the MPO-H2O2-Cl system because of the compromised Cl transport seen in CF. We will discuss first how the MPO-H2O2-Cl system in healthy PMNs participates in host defense and resolution of inflammation and then review how a defective MPO-H2O2-Cl system contributes to the increased susceptibility to infection and dysregulated inflammation associated with the clinical manifestations of CF.

Indexed as

Cystic FibrosisLeukocyte DisordersChloridesHumansHydrogen PeroxideHypochlorous AcidInflammationNeutrophilsPeroxidaseChloridesHydrogen PeroxideHypochlorous AcidPeroxidase

Identifiers

PMID35213685
PMCPMC9053701
OpenAlexW4214753796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.